4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000090
Director sold 100 shares at an average $962.53 ($96,253)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
RYAN ARTHUR F · Director
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-01 | Sale : show line 1 in the form 10b5-1 | −2 | $957.78 | $1,916 | 18,280 | D |
| 2024-04-01 | Sale : show line 2 in the form 10b5-1 | −2 | $958.86 | $1,918 | 18,278 | D |
| 2024-04-01 | Sale : show line 3 in the form 10b5-1 | −9 | $959.47 | $8,635 | 18,269 | D |
| 2024-04-01 | Sale : show line 4 in the form 10b5-1 | −15 | $960.53 | $14,408 | 18,254 | D |
| 2024-04-01 | Sale : show line 5 in the form 10b5-1 | −14 | $961.59 | $13,462 | 18,240 | D |
| 2024-04-01 | Sale : show line 6 in the form 10b5-1 | −9 | $962.42 | $8,662 | 18,231 | D |
| 2024-04-01 | Sale : show line 7 in the form 10b5-1 | −20 | $963.60 | $19,272 | 18,211 | D |
| 2024-04-01 | Sale : show line 8 in the form 10b5-1 | −16 | $964.45 | $15,431 | 18,195 | D |
| 2024-04-01 | Sale : show line 9 in the form 10b5-1 | −13 | $965.35 | $12,550 | 18,182 | D |
| Open-market sales · 100 sh · avg $962.53 · $96,253 | ||||||
Loading xslF345X05/edgardoc.xml…